Evidence map›Paper›PMID 41285973›Full record

ArticleScientific reports2025

Machine learning estimating paracetamol solubility in supercritical CO

Kamal Y Thajudeen, Saad Ali Alshehri, Mohamed Rahamathulla, Mohammed Muqtader Ahmed

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kamal Y ThajudeenDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia. kthajudeen@kku.edu.sa.
Saad Ali AlshehriDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.
Mohamed RahamathullaDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Abha, 62529, Saudi Arabia.
Mohammed Muqtader AhmedDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, AlKharj, 11942, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Because of extensive usage of paracetamol by patients, its solubility improvement would have major impact on wellbeing. Supercritical processing can be used for nanonization of drug particles which in turn increases their solubility and consequently low dosage of drug for patients. This study presents the results of Neighbor-based ensemble models for predicting the mole fraction of paracetamol drug in supercritical solvent as well as solvent density at different conditions. The models were trained and evaluated using data of 40 instances. The K-nearest neighbor regression algorithm selected here as the base model, and ensemble methods of bagging and AdaBoost, were employed for model improvement. Additionally, two metaheuristic algorithms, BAT and GWO, were applied to adjust the hyperparameters of the models. The assessment of each model's performance was conducted through the utilization of three metrics, namely the R-squared score, MSE, and AARD percentage. The outcomes showed that the GWO-ADA-KNN model demonstrated superior performance in predicting both mole fraction and density, as evidenced by its respective R-squared scores of 0.98105 and 0.96719. These findings indicate that the proposed optimizer and models can predict accurately drug mole fraction and density under different conditions.

Indexed as

AcetaminophenCarbon DioxideMachine LearningAlgorithmsSolubilitySolventsAcetaminophenCarbon DioxideSolventsMachine learningMetaheuristic algorithmsSolubilitySupercritical CO2

Identifiers

PMID41285973
PMCPMC12647129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.